Methicillin-resistant Staphylococcus aureus: The latest health scare

Mayo Clinic Proceedings

Volumn 82, Issue 12, 2007, Pages 1463-1467

  Sampathkumar, Priya ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTOBIPROLE; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DAPTOMYCIN; LINEZOLID; MACROLIDE; MINOCYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM TRANSDUCTION; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; DISEASE COURSE; DISEASE TRANSMISSION; DRUG SENSITIVITY; EDITORIAL; EPIDEMIC; GENE CASSETTE; HEALTH CARE ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; HOSPITAL INFECTION; HYGIENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; PATHOGENESIS; PATIENT CARE; PNEUMONIA; PREVALENCE; PREVENTION AND CONTROL; PUBLIC HEALTH PROBLEM; RISK FACTOR; STAPHYLOCOCCAL GENE CASSETTE; STAPHYLOCOCCUS INFECTION; SURGICAL DRAINAGE; TREATMENT INDICATION;

EID: 36749095146     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.12.1463     Document Type: Editorial

References (44)

1. Klevens RM, Morrison MA, Nadle J, et al, Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.
2. Pitts L Jr. Media fall victim to the journalism of fear. LJWorld.com. November 5, 2007. Available at: http://www2.ljworld.com/news/2007/nov/05/ media_fall_victim_journalism_fear/. Accessed November 7, 2007.
3. Staph outbreak prompts legislation. Chicago Tribune. October 29, 2007. Available at: www.chicagotribune.com/news/local/chi-durbinoct29,0,6847984. story?coll=chi_tab01_layout. Accessed November 7, 2007.
4. Hester T. NJ law requires hospitals to report infections. The Philadelphia Inquirer. November 1, 2007. Available at: www.philly.com/ inquirer/health_science/daily/ 20071101_N_J_law_requires_hospitals_to_report_infections.html. Accessed November 7, 2007.
5. Gormley M. States consider new laws to fight spread of staph infections. Press and Sun Bulletin, Greater Binghampton, NY. October 27, 2007. Available at: http://forums.pressconnects.com/viewtopic.php?t=11922. Accessed November 7, 2007.
6. Stewart GT, Holt RJ. Evolution of natural resistance to the newer penicillins. Br Med J. 1963;1(5326):308-311.
7. Barrett FF, McGehee RFJr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations . N Engl J Med. 1968;279(9):441-448.
8. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-485.
9. Centers for Disease Control and Prevention (CDC). Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997 [published correction appears in MMWR Morb Mortal Wkly Rep. 1997; 46(36):851]. MMWR Morb Mortal Wkly Rep. 1997;46(35):813-815.
10. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51(26):565-567.
11. Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA. 1999;282(12):1123-1125.
12. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep. 2003;52(41):992-996.
13. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352(5):468-475.
14. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 1998;158(8):895-899.
15. Jensen JU, Jensen ET, Larsen AR, et al. Control of a methicillin- resistant Staphylococcus aureus (MRSA) outbreak in a day-care institution. J Hosp Infect. 2006 May;63(1):84-92. Epub 2006 Mar 15.
16. Centers for Disease Control and Prevention (CDC). Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns - Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep. 2006;55(12):329-332.
17. Beilman GJ, Sandifer G, Skarda D, et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital. Surg Infect (Larchmt). 2005 Spring;6(1):87-92.
18. Pagac BB, Reiland RW, Bolesh DT, Swanson DL. Skin lesions in barracks: consider community-acquired methicillin-resistant Staphylococcus aureus infection instead of spider bites. Mil Med. 2006;171(9):830-832.
19. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients - Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006;55(24):677-679.
20. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc. 2005;80(9):1201-1208.
21. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144(5):309-317.
22. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006 - January 2007. MMWR Morb Mortal Wkly Rep. 2007;56(14):325-329.
23. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445-1453.
24. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007 Feb 23;315(5815):1130-1133. Epub 2007 Jan 18.
25. McCollister BD, Kreiswirth BN, Novick RP, Schlievert PM. Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A. Infect Immun. 1990;58(7):2067- 2070.
26. Omoe K, Ishikawa M, Shimoda Y, Hu DL, Ueda S, Shinagawa K. Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates harboring seg, seh, or sei genes. J Clin Microbiol. 2002;40(3):857-862.
27. David MD, Kearns AM, Gossain S, Ganner M, Holmes A. Community-associated methicillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect. 2006 Nov;64(3):244-250. Epub 2006 Aug 22.
28. Davis SL, Rybak MJ, Amjad M, Kaatz GW, McKinnon PS. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2006 Oct;27(10):1025-1031. Epub 2006 Sep 19.
29. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Increasing incidence of sterile-site infections due to non-multidrug-resistant, oxacillin-resistant Staphylococcus aureus among hospitalized patients. Infect Control Hosp Epidemiol. 2007 Jan;28(1):95-97. Epub 2006 Dec 20.
30. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006 Mar 1;42(5):647-656. Epub 2006 Jan 25.
31. Han LL, McDougal LK, Gorwitz RJ, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol. 2007 Apr;45(4):1350-1352. Epub 2007 Feb 7.
32. Graham PL III, Lin SX, Larson EL. A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006;144(5):318-325.
33. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003 Feb 1;36(3):281-285. Epub 2003 Jan 17.
34. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-279. Epub 2007 Feb 15.
35. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol. 2000;21(10):645-648.
36. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States [published correction appears in Emerg Infect Dis. 2006;12(9):1472]. Emerg Infect Dis. 2005;11(6):868-872.
37. Association for Professionals in Infection Control and Epidemiology, Inc (APIC). Guide to the elimination of methicillin-resistant Staphylococcus aureus (MRSA) transmission in hospital settings, March 2007. Available at: www.apic.org/Content/NavigationMenu/GovernmentAdvocacy/ MethicillinResistantStaphylococcusAureusMRSA/Resources/MRSAguide.pdf. Accessed November 8, 2007.
38. Huang SS, Datta R, Piatt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006;166(18):1945- 1951.
39. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. Available at: www.cdc.gov/ncidod/dhqp/gl_isolation.html. Accessed November 8, 2007.
40. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Available at: http://0-www.cdc.gov. milll.sjlibrary.org/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed November 8, 2007.
41. van Trijp MJ, Melles DC, Hendriks WD, Parlevliet GA, Gommans M, Ott A. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol. 2007 Aug;28(8):970-975. Epub 2007 Jun 19.
42. Vos MC, Ott A, Verbrugh HA. Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in The Netherlands [letter]. J Clin Microbiol. 2005;43(4):2034.
43. Jones RN. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis. 2006;42(suppl 1):S13-S24.
44. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006 Nov;44(11):3883-3886. Epub 2006 Sep 6.